RecruitingNot Applicable

Closed-blood Sampling Devices in the Adult Critically Ill Patient

Spain216 participantsStarted 2024-11-11

Plain-language summary

Based on the hypothesis that the strategy of using Closed-Blood Sampling Devices (CSBD, experimental group) compared to the usual practice (waste discard volume, control group), in critically ill adult patients, will decrease the amount of blood withdrawn for laboratory tests, we want to analyze the number of red blood cells (RBC) administered and arterial catheter-related adverse events (catheter-related bacteremia, catheter obstruction, CBSD malfunction, loss of arterial pressure waveform on the patient's bedside monitor) in both study groups, during ICU stay and up to a maximum of 21 days.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients with an arterial catheter who agree to participate in the study, with a stay in the ICU of 24h and a minimum of 72h more with an arterial catheter Non-inclusion criteria: Therapeutic Limitation of Life Support, Jehovah's Witnesses. Exclusion Criteria: * Patients with chronic renal failure * Patients with active gastrointestinal bleeding * Patients diagnosed with hematologic cancer * Women with menstruation at the time of admission * Pregnant women Withdrawal criteria: presence of active gastrointestinal bleeding during the study inclusion period.

What they're measuring

Units of red blood cells transfusion

Timeframe: Every day during the ICU stay and up to a maximum of 21 days after randomization (day 0)

Trial details

NCT IDNCT06478160

SponsorUniversity of Barcelona

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-07

Contact for this trial

Raurell-Torreda Marta, PhD

626154955 mraurell@ub.edu

View on ClinicalTrials.gov More Acceptability of Health Care trials